文献速递临床试验与 GCP流行病学与生物统计

药师主导教育干预对老年人不适当处方的效果:D-PRESCRIBE随机临床试验

Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

在加拿大魁北克省69家社区药房开展的整群随机试验中,药师向65岁及以上正在服用4类Beers标准不适当药物的患者发送教育宣传册,同时向其医生发送循证药学意见。6个月时干预组43%患者停用不适当药物,对照组仅12%,风险差31%(95%CI 23%至38%)。

要点

  • 药师主导的患者教育+医生药学意见可显著提高老年人不适当药物停用率(43% vs 12%)。
  • 镇静催眠药、格列本脲和NSAIDs的停用率在干预组均高于对照组。
  • 尝试减停镇静催眠药的患者中38%报告戒断症状,但无需要住院的不良事件。

核心结论

  • 在魁北克社区居住的老年人中,与常规照护相比,药师主导的教育干预在6个月时使更多患者停用了不适当药物处方。
  • 研究结果的普适性需要进一步研究验证。

研究设计与样本

  • 整群随机临床试验(D-PRESCRIBE),2014年2月至2017年9月在加拿大魁北克省招募社区药房,随访至2018年2月。
  • 共纳入69家社区药房,随机分配34家药房(248例患者)至干预组、35家药房(241例患者)至对照组。
  • 纳入对象为65岁及以上、正在服用4类Beers标准药物(镇静催眠药、第一代抗组胺药、格列本脲或非甾体抗炎药)之一的成年人。
  • 共489例患者,平均年龄75岁,66%为女性;437例(89%)完成试验(干预组219例[88%],对照组218例[91%])。
  • 患者、医生、药师和评估者对结局评估设盲。

主要发现

  • 6个月时,干预组248例中106例(43%)不再配取不适当药物,对照组241例中29例(12%),风险差31%(95%CI 23%至38%)。
  • 镇静催眠药使用者中,干预组146例中63例(43.2%)停用,对照组155例中14例(9.0%),风险差34%(95%CI 25%至43%)。
  • 格列本脲使用者中,干预组62例中19例(30.6%)停用,对照组58例中8例(13.8%),风险差17%(95%CI 2%至31%)。
  • 抗组胺药类别因样本量小(n=12)无法分析;无需要住院的不良事件报告,但尝试减停镇静催眠药的77例患者中29例(38%)报告戒断症状。

关键数值与推荐

  • 主要结局为6个月时不适当药物处方的停用,通过药房药物续配记录确定。
  • 干预组药师被鼓励向患者发送教育性减处方宣传册,同时向医生发送循证药学意见以推荐减处方。
  • 对照组药师提供常规照护。
  • 随机化在药房层面进行。

临床怎么用

  • 在社区药房场景中,可考虑由药师主导、同时面向患者和处方医生的教育干预来促进老年人不适当药物减停。
  • 对镇静催眠药减停过程应关注戒断症状,本研究中38%尝试减停者报告戒断症状。

局限性

  • 研究仅在加拿大魁北克省开展,结果推广至其他环境需进一步研究。
  • 抗组胺药类别因样本量小(n=12)无法分析。
  • 镇静催眠药减停者中戒断症状报告率较高(38%),需在干预中加以监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: High rates of inappropriate prescribing persist among older adults in many outpatient settings, increasing the risk of adverse drug events and drug-related hospitalizations. OBJECTIVE: To compare the effectiveness of a consumer-targeted, pharmacist-led educational intervention vs usual care on discontinuation of inappropriate medication among community-dwelling older adults. DESIGN, SETTING, AND PARTICIPANTS: A cluster randomized trial (D-PRESCRIBE [Developing Pharmacist-Led Research to Educate and Sensitize Community Residents to the Inappropriate Prescriptions Burden in the Elderly]) that recruited community pharmacies in Quebec, Canada, from February 2014 to September 2017, with follow-up until February 2018, and randomly allocated them to intervention or control groups. Patients included were adults aged 65 years and older who were prescribed 1 of 4 Beers Criteria medications (sedative-hypnotics, first-generation antihistamines, glyburide, or nonsteroidal anti-inflammatory drugs), recruited from 69 community pharmacies. Patients were screened and enrolled before randomization. INTERVENTIONS: Pharmacists in the intervention group were encouraged to send patients an educational deprescribing brochure in parallel to sending their physicians an evidence-based pharmaceutical opinion to recommend deprescribing. The pharmacists in the control group provided usual care. Randomization occurred at the pharmacy level, with 34 pharmacies randomized to the intervention group (248 patients) and 35 to the control group (241 patients). Patients, physicians, pharmacists, and evaluators were blinded to outcome assessment. MAIN OUTCOMES AND MEASURES: Discontinuation of prescriptions for inappropriate medication at 6 months, ascertained by pharmacy medication renewal profiles. RESULTS: Among 489 patients (mean age, 75 years; 66% women), 437 (89%) completed the trial (219 [88%] in the intervention group vs 218 [91%] in the control group). At 6 months, 106 of 248 patients (43%) in the intervention group no longer filled prescriptions for inappropriate medication compared with 29 of 241 (12%) in the control group (risk difference, 31% [95% CI, 23% to 38%]). In the intervention vs control group, discontinuation of inappropriate medication occurred among 63 of 146 sedative-hypnotic drug users (43.2%) vs 14 of 155 (9.0%), respectively (risk difference, 34% [95% CI, 25% to 43%]); 19 of 62 glyburide users (30.6%) vs 8 of 58 (13.8%), respectively (risk difference, 17% [95% CI, 2% to 31%]); and 19 of 33 nonsteroidal anti-inflammatory drug users (57.6%) vs 5 of 23 (21.7%), respectively (risk difference, 35% [95% CI, 10% to 55%]) (P for interaction = .09). Analysis of the antihistamine drug class was not possible because of the small sample size (n = 12). No adverse events requiring hospitalization were reported, although 29 of 77 patients (38%) who attempted to taper sedative-hypnotics reported withdrawal symptoms. CONCLUSIONS AND RELEVANCE: Among older adults in Quebec, a pharmacist-led educational intervention compared with usual care resulted in greater discontinuation of prescriptions for inappropriate medication after 6 months. The generalizability of these findings to other settings requires further research. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02053194.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Martin P, Tamblyn R, Benedetti A, et al. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018. PMID: 30422193. doi:10.1001/jama.2018.16131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。